The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found.The study, led by...
The labs of two Yale scientists will receive $1 million from Connecticut Bioscience Innnovation Fund.Connecticut Innovations Inc. announced $1.8 million in funding for the second quarter under the state fund, which will allocate $200 million to help...
MicroRNAs may be tiny — as few as 20 genetic letters, compared to 3 billion in the DNA of a human — but they play a major role in biology, helping to determine which genes are expressed or silenced. In the last 10 years, researchers at Yale and elsewhere...